CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Growth in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,549,897 shares, an increase of 70,145.1% from the April 30th total of 3,630 shares. Based on an average daily volume of 57,447,441 shares, the days-to-cover ratio is presently 0.0 days.

CNBX Pharmaceuticals Trading Down 33.3%

OTCMKTS:CNBX opened at $0.00 on Friday. CNBX Pharmaceuticals has a one year low of $0.00 and a one year high of $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.